Breaking News

Norwegian Cruise to Buy Prestige Cruises for $3.03 Billion With Debt
Tweet TWEET

AAAResearchReports.com Pre-Market Scrutiny: Rite Aid, CVS Caremark, Walgreen, and GNC Holdings

AAAResearchReports.com Pre-Market Scrutiny: Rite Aid, CVS Caremark, Walgreen,
                               and GNC Holdings

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, December 27, 2013

LONDON, December 27, 2013 /PRNewswire/ --

On Thursday, December 26, 2013, the U.S. equity market edged higher. The S&P
500 ended the day at 1,842.02, up 0.47%; the Dow Jones Industrial Average
closed at 16,479.88, up 0.75%; and the NASDAQ Composite Index finished at
4,167.18, up 0.28%. The S&P 500 Consumer Staples Sector Index edged 0.44%
higher to end the day at 440.43. The S&P 500 Drug Retail Sub Industry Index
ended at 937.50, up 0.30%; and the same has edged 2.65% in the last one month
and 16.00% in the previous three months, outperforming the S&P 500, which has
advanced 2.19% and 8.82%, during the respective periods. The major movers in
the industry included Rite Aid Corporation (NYSE: RAD), CVS Caremark
Corporation (NYSE: CVS), Walgreen Company (NYSE: WAG), and GNC Holdings Inc.
(NYSE: GNC). AAAResearchReports.com initiated preliminary technical research
on RAD, CVS, WAG, and GNC. These free reports are accessible by signing today
at:

http://www.aaaresearchreports.com/register/ 

On Thursday, shares in Rite Aid Corp. edged lower to end the day at $5.17,
down 0.19% from the previous day's closing price of $5.18. The company's
shares fluctuated between $5.15 and $5.25 during the trading session. A total
of 12.33 million shares were traded, which is below the daily average volume
of 30.12 million. Despite Thursday's losses, the company's shares have gained
3.61% in the previous three trading sessions and 8.16% in the last three
months, compared to a gain of 1.30% and 8.82% in the S&P 500 during the
respective periods. Moreover, Rite Aid Corp.'s stock is trading above its
200-day moving average of $3.64. The free technical analysis on RAD is
available by signing up at:

www.AAAResearchReports.com/RAD122713.pdf

Shares in CVS Caremark Corp. edged higher on Thursday, hitting a new 52-week
high of $71.40. The company's stock ended the day at $71.28, up 0.42% from the
previous day's closing price of $70.98. A total of 2.37 million shares were
traded, which is below the daily average volume of 5.71 million. The company's
shares have gained 7.85% in the last one month and 22.54% in the previous
three months, outperforming the S&P 500, which has gained 2.19% and 8.82%,
during the respective periods. Moreover, CVS Caremark Corp.'s stock is trading
above its 50-day and 200-day moving averages of $64.96 and $60.01,
respectively. Register now to download free research on CVS at:

www.AAAResearchReports.com/CVS122713.pdf

On Thursday, Walgreen Co.'s stock finished the day at $57.67, which is 0.10%
higher than the previous day's closing price of $57.61. The company's shares
vacillated between $57.33 and $57.85 during the trading session. A total of
2.49 million shares were traded, which is below the daily average volume of
5.78 million. The company's shares have gained 5.37% in the previous three
months, underperforming the S&P 500, which has advanced 8.82%, during the same
period. Additionally, Walgreen Co.'s stock is trading above its 200-day moving
average of $51.84. A free report on WAG can be accessed by registering at:

www.AAAResearchReports.com/WAG122713.pdf

Shares in GNC Holdings Inc. advanced on Thursday, closing the day 0.52% higher
at $58.28, after trading between $58.02 and $58.59. A total of 0.28 million
shares were traded, which is below the daily average volume of 1.04 million.
The company's shares have gained 1.34% in the previous three trading sessions
and 7.59% in the last three months, compared to a gain of 1.30% and 8.82% in
the S&P 500 during the respective periods. Furthermore, GNC Holdings Inc.'s
stock is trading above its 200-day moving average of $50.20. Register with AAA
Research Reports and download research on GNC for free at:

www.AAAResearchReports.com/GNC122713.pdf

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

SOURCE AAA Research Reports

Contact: :#: + 1 (646) 396-9126 Contact Name: Peter F. Jones
 
Press spacebar to pause and continue. Press esc to stop.